Thông tin thuốc gốc
Chỉ định và Liều dùng
Adult: Initially, 75 mg daily as a single or in divided doses at night, may increase to 150 mg daily. In severe cases, may increase up to 225 mg daily.
Elderly: Initially, 50-75 mg daily in divided doses. Maintenance: Half the normal adult dose.
Hepatic Impairment
Cách dùng
May be taken with or without food.
Chống chỉ định
Manic phase of bipolar disorder, arrhythmias, heart block, immediate recovery period after MI. Hepatic impairment. Concomitant admin w/ MAOIs or w/in 14 days after discontinuation.
Thận trọng
Patient w/ history of bipolar disorder and psychosis. Patient w/ severe CV disease including heart failure, conduction disorders or cardiac arrhythmia; risk factors for QTc prolongation/TdP including congenital long QT syndrome; significant risk of suicide; glaucoma, urinary retention, prostatic hypertrophy. Avoid abrupt withdrawal. Elderly. Pregnancy and lactation.
Phản ứng phụ
Drowsiness, dizziness, tremor, confusional states, paraesthesia, EEG patterns alterations, disorientation; dry mouth, urinary retention, sweating; hypotension, postural hypotension, tachycardia, arrhythmias (including ventricular tachycardia, ventricular fibrillation and torsades de pointes), conduction defects, palpitations; increased or decreased libido; constipation, nausea, vomiting; blurred vision. Rarely, dysarthria, extrapyramidal symptoms, paralytic ileus, tremor, neuroleptic malignant syndrome, precipitation of angle-closure glaucoma.
Thông tin tư vấn bệnh nhân
This drug may cause drowsiness, if affected do not drive or operate machinery.
Closely monitor for clinical worsening and suicidality (esp at the beginning of the treatment and dose change). Perform ECG prior to treatment. Monitor CV and ECG. Examine eyes regularly during prolonged treatment.
Quá liều
Symptoms: Dry mouth, blurred vision, paralytic ileus, mydriasis, urinary retention; agitation, ataxia, hyperpyrexia, delirium, convulsions, resp depression, coma, unconsciousness, muscle twitching, hyperreflexia, hypothermia, resp or metabolic alkalosis, visual hallucinations; cyanosis, shock, hypotension, tachycardia, cardiac arrhythmias (including torsades de pointes), QTc prolongation, conduction disorders, heart failure, rarely cardiac arrest. Management: Ensure a clear airway and adequate ventilation. Correct hypoxia and acid-based imbalance by assisted ventilation and IV Na bicarbonate, as needed. Admin activated charcoal w/in 2 hr prior to ingestion. Persist w/ prolonged CPR (at least an hr) for cardiac arrest. Admin of IV diazepam or lorazepam may control convulsions.
Tương tác
Increased risk of ventricular arrhythmias w/ drugs that prolong QT interval. May potentiate sedative effect w/ barbiturates, tranquilisers, CNS depressants. May block antihypertensive effect of guanethidine and other adrenergic neurone blocking drugs. May potentiate effects of anticholinergics, antihistamines, sympathomimetics. Increased risk of postural hypotension w/ diuretics. May antagonise effect of antiepileptics.
Potentially Fatal: Concomitant admin w/ MAOIs or w/in 14 days after discontinuation may cause cerebral excitation followed by coma or dangerous hyperthermia.
Food Interaction
May potentiate effect of alcohol.
Tác dụng
Description: Dosulepin hydrochloride (also known as dothiepin) is a TCA which inhibits norepinephrine and 5-hydroxytryptamine uptake from the nerve endings, thereby increases availability at central norepinephrine synapses. It has anticholinergic, antihistamine and central sedative properties.
Absorption: Readily absorbed from the GI tract.
Distribution: Enters breast milk (low concentration). Plasma protein binding: Approx 84% (as unchanged drug).
Metabolism: Extensively demethylated by first-pass hepatic metabolism to its primary active metabolite, desmethyldothiepin (northiaden).
Excretion: Via urine (mainly as metabolites); faeces (small amounts). Elimination half-life: Approx 14-24 hr (dosulepin); 23-46 hr (metabolites).
Đặc tính

Chemical Structure Image

Source: National Center for Biotechnology Information. PubChem Database. Dosulepin, CID=5284550, (accessed on Jan. 21, 2020)

Bảo quản
Store below 25°C.
Phân loại MIMS
Phân loại ATC
N06AA16 - dosulepin ; Belongs to the class of non-selective monoamine reuptake inhibitors. Used in the management of depression.
Anon. Dosulepin. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. Accessed 14/03/2016.

Buckingham R (ed). Dosulepin Hydrochloride. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. Accessed 14/03/2016.

Joint Formulary Committee. Dosulepin Hydrochloride (Dothiepin Hydrochloride). British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. Accessed 14/03/2016.

Mylan New Zealand Limited. Dopress Capsules 25 mg and Tablets 75 mg data sheet 8 April 2014. Medsafe. Accessed 14/03/2016.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Dosulepin từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2021 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi
  • Prothiaden
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in